Systemically inoculated adjuvants stimulate pDC-dependent IgA response in local site
The stimulation of local immunity by vaccination is desirable for controlling virus replication in the respiratory tract. However, the local immune stimulatory effects of adjuvanted vaccines administered through the non-mucosal route are poorly understood. Here, we clarify the mechanisms by which no...
Saved in:
| Published in | Mucosal immunology Vol. 16; no. 3; pp. 275 - 286 |
|---|---|
| Main Authors | , , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Elsevier Inc
01.06.2023
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | The stimulation of local immunity by vaccination is desirable for controlling virus replication in the respiratory tract. However, the local immune stimulatory effects of adjuvanted vaccines administered through the non-mucosal route are poorly understood. Here, we clarify the mechanisms by which non-mucosal inoculation of adjuvants stimulates the plasmacytoid dendritic cell (pDC)-dependent immunoglobulin (Ig)A response in the lungs. After systemic inoculation with type 1 interferon (IFN)-inducing adjuvants, type 1 IFN promotes CXCL9/10/11 release from alveolar endothelial and epithelial cells and recruits CXCR3-expressing pDCs into the lungs. Because adjuvant-activated pulmonary pDCs highly express major histocompatibility complex II, cluster of differentiation 80, and cluster of differentiation 86, transplantation of such cells into the lungs successfully enhances antigen-specific IgA production by the intranasally sensitized vaccine. In contrast, pDC accumulation in the lungs and subsequent IgA production are impaired in pDC-depleted mice and Ifnar1−/− mice. Notably, the combination of systemic inoculation with type 1 IFN-inducing adjuvants and intranasal antigen sensitization protects mice against influenza virus infection due to the pDC-dependent IgA response and type I IFN response. Our results provide insights into the novel mucosal vaccine strategies using non-mucosal inoculated adjuvants. |
|---|---|
| AbstractList | The stimulation of local immunity by vaccination is desirable for controlling virus replication in the respiratory tract. However, the local immune stimulatory effects of adjuvanted vaccines administered through the non-mucosal route are poorly understood. Here, we clarify the mechanisms by which non-mucosal inoculation of adjuvants stimulates the plasmacytoid dendritic cell (pDC)-dependent immunoglobulin (Ig)A response in the lungs. After systemic inoculation with type 1 interferon (IFN)-inducing adjuvants, type 1 IFN promotes CXCL9/10/11 release from alveolar endothelial and epithelial cells and recruits CXCR3-expressing pDCs into the lungs. Because adjuvant-activated pulmonary pDCs highly express major histocompatibility complex II, cluster of differentiation 80, and cluster of differentiation 86, transplantation of such cells into the lungs successfully enhances antigen-specific IgA production by the intranasally sensitized vaccine. In contrast, pDC accumulation in the lungs and subsequent IgA production are impaired in pDC-depleted mice and Ifnar1
mice. Notably, the combination of systemic inoculation with type 1 IFN-inducing adjuvants and intranasal antigen sensitization protects mice against influenza virus infection due to the pDC-dependent IgA response and type I IFN response. Our results provide insights into the novel mucosal vaccine strategies using non-mucosal inoculated adjuvants. The stimulation of local immunity by vaccination is desirable for controlling virus replication in the respiratory tract. However, the local immune stimulatory effects of adjuvanted vaccines administered through the non-mucosal route are poorly understood. Here, we clarify the mechanisms by which non-mucosal inoculation of adjuvants stimulates the plasmacytoid dendritic cell (pDC)-dependent immunoglobulin (Ig)A response in the lungs. After systemic inoculation with type 1 interferon (IFN)-inducing adjuvants, type 1 IFN promotes CXCL9/10/11 release from alveolar endothelial and epithelial cells and recruits CXCR3-expressing pDCs into the lungs. Because adjuvant-activated pulmonary pDCs highly express major histocompatibility complex II, cluster of differentiation 80, and cluster of differentiation 86, transplantation of such cells into the lungs successfully enhances antigen-specific IgA production by the intranasally sensitized vaccine. In contrast, pDC accumulation in the lungs and subsequent IgA production are impaired in pDC-depleted mice and Ifnar1−/− mice. Notably, the combination of systemic inoculation with type 1 IFN-inducing adjuvants and intranasal antigen sensitization protects mice against influenza virus infection due to the pDC-dependent IgA response and type I IFN response. Our results provide insights into the novel mucosal vaccine strategies using non-mucosal inoculated adjuvants. The stimulation of local immunity by vaccination is desirable for controlling virus replication in the respiratory tract. However, the local immune stimulatory effects of adjuvanted vaccines administered through the non-mucosal route are poorly understood. Here, we clarify the mechanisms by which non-mucosal inoculation of adjuvants stimulates the plasmacytoid dendritic cell (pDC)-dependent immunoglobulin (Ig)A response in the lungs. After systemic inoculation with type 1 interferon (IFN)-inducing adjuvants, type 1 IFN promotes CXCL9/10/11 release from alveolar endothelial and epithelial cells and recruits CXCR3-expressing pDCs into the lungs. Because adjuvant-activated pulmonary pDCs highly express major histocompatibility complex II, cluster of differentiation 80, and cluster of differentiation 86, transplantation of such cells into the lungs successfully enhances antigen-specific IgA production by the intranasally sensitized vaccine. In contrast, pDC accumulation in the lungs and subsequent IgA production are impaired in pDC-depleted mice and Ifnar1-/- mice. Notably, the combination of systemic inoculation with type 1 IFN-inducing adjuvants and intranasal antigen sensitization protects mice against influenza virus infection due to the pDC-dependent IgA response and type I IFN response. Our results provide insights into the novel mucosal vaccine strategies using non-mucosal inoculated adjuvants.The stimulation of local immunity by vaccination is desirable for controlling virus replication in the respiratory tract. However, the local immune stimulatory effects of adjuvanted vaccines administered through the non-mucosal route are poorly understood. Here, we clarify the mechanisms by which non-mucosal inoculation of adjuvants stimulates the plasmacytoid dendritic cell (pDC)-dependent immunoglobulin (Ig)A response in the lungs. After systemic inoculation with type 1 interferon (IFN)-inducing adjuvants, type 1 IFN promotes CXCL9/10/11 release from alveolar endothelial and epithelial cells and recruits CXCR3-expressing pDCs into the lungs. Because adjuvant-activated pulmonary pDCs highly express major histocompatibility complex II, cluster of differentiation 80, and cluster of differentiation 86, transplantation of such cells into the lungs successfully enhances antigen-specific IgA production by the intranasally sensitized vaccine. In contrast, pDC accumulation in the lungs and subsequent IgA production are impaired in pDC-depleted mice and Ifnar1-/- mice. Notably, the combination of systemic inoculation with type 1 IFN-inducing adjuvants and intranasal antigen sensitization protects mice against influenza virus infection due to the pDC-dependent IgA response and type I IFN response. Our results provide insights into the novel mucosal vaccine strategies using non-mucosal inoculated adjuvants. |
| Author | Hamaguchi, Isao Furuhata, Keiko Takahashi, Yoshimasa Asanuma, Hideki Mizukami, Takuo Momose, Haruka Matsumura, Takayuki Sasaki, Eita |
| Author_xml | – sequence: 1 givenname: Eita orcidid: 0000-0002-3384-7414 surname: Sasaki fullname: Sasaki, Eita email: esasaki@niid.go.jp organization: Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 2 givenname: Hideki surname: Asanuma fullname: Asanuma, Hideki organization: Center for Influenza and Respiratory Virus Research, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 3 givenname: Haruka surname: Momose fullname: Momose, Haruka organization: Research Center for Biological Products in the Next Generation, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 4 givenname: Keiko surname: Furuhata fullname: Furuhata, Keiko organization: Research Center for Biological Products in the Next Generation, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 5 givenname: Takuo surname: Mizukami fullname: Mizukami, Takuo organization: Research Center for Biological Products in the Next Generation, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 6 givenname: Takayuki surname: Matsumura fullname: Matsumura, Takayuki organization: Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 7 givenname: Yoshimasa surname: Takahashi fullname: Takahashi, Yoshimasa organization: Research Center for Drug and Vaccine Development, National Institute of Infectious Diseases, Tokyo, Japan – sequence: 8 givenname: Isao surname: Hamaguchi fullname: Hamaguchi, Isao organization: Research Center for Biological Products in the Next Generation, National Institute of Infectious Diseases, Tokyo, Japan |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/36935091$$D View this record in MEDLINE/PubMed |
| BookMark | eNqFkU9r2zAYh8VIWdJu32AMH3dxpj-2YpcyCGm7Fgo7rDsLWXo9lMmSK8mFfPsqTdZDL4EX9CI9z-_w0zmaOe8AoS8ELwkm_Pt2OUzKDMOSYsqWOA9mH9CCtKwuWVXz2evOSkxJO0fnMW4x5hjX7COaM54p3JIFevy9iwkGo6S1u8I4ryYrE-hC6u30LF2KRUxmeL0sxutNqWEEp8Gl4v7vuggQR-8iZLOwPocU0ST4hM56aSN8Pp4X6M_tzePmrnz49fN-s34oVU1XqZRqpTnpWi4b1nd1y1vAlW6gl1SvQFU1pYy1vCYMFOlIt99p1wNpmMovPbtA3w65Y_BPE8QkBhMVWCsd-CkKumqaBlek4Rn9ekSnbgAtxmAGGXbifxMZqA6ACj7GAP0bQrDYFy624lC42BcucB7Msnb5TlMmyWS8S0Eae0r-cZAhl_RsIIioDDgF2gRQSWhvTgVcvQtQ1rj9Z_6D3Wn9BZXVsvg |
| CitedBy_id | crossref_primary_10_3390_ijms25042132 |
| Cites_doi | 10.4049/jimmunol.168.6.2930 10.1073/pnas.1610630114 10.1159/000508379 10.1002/eji.200838155 10.1172/JCI78578 10.1038/nri2358 10.1111/j.1365-2222.2008.03056.x 10.4049/jimmunol.167.12.7084 10.1038/nm1213 10.4049/jimmunol.0901466 10.1016/j.immuni.2011.02.002 10.4049/jimmunol.1700382 10.1038/nri3027 10.4049/jimmunol.171.12.6466 10.1016/j.it.2010.05.004 10.7883/yoken.JJID.2015.560 10.4049/jimmunol.1000454 10.1189/jlb.71.5.813 10.1038/nri2322 10.1038/emm.2014.16 10.1586/erv.11.196 10.1016/j.ctrv.2017.11.007 10.1073/pnas.1311760110 10.1084/jem.20150567 10.4049/jimmunol.173.3.1978 10.1016/j.vaccine.2013.02.016 10.1016/j.micinf.2007.06.007 10.1086/521304 10.1038/nri3251 10.1126/scitranslmed.3000759 10.1016/j.immuni.2008.09.002 10.3389/fimmu.2013.00372 10.1056/NEJMoa030595 10.1016/j.cell.2006.02.019 10.1128/JVI.00213-12 10.1038/mi.2016.99 10.4049/jimmunol.179.7.4711 10.1189/jlb.1203644 10.1038/nature06033 10.4049/jimmunol.173.11.6592 10.1038/s41590-019-0345-x 10.4049/jimmunol.0902022 10.4049/jimmunol.1101764 10.1111/j.1749-6632.2011.06378.x 10.1038/sj.cdd.4401850 10.1007/s10875-007-9087-x 10.1084/jem.20040035 10.1084/jem.20041930 10.1038/srep46426 10.1111/j.1600-065X.2008.00731.x 10.1016/j.immuni.2007.08.006 10.1128/JVI.01262-19 |
| ContentType | Journal Article |
| Copyright | 2023 The Author(s) Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved. |
| Copyright_xml | – notice: 2023 The Author(s) – notice: Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved. |
| DBID | 6I. AAFTH AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1016/j.mucimm.2023.03.003 |
| DatabaseName | ScienceDirect Open Access Titles Elsevier:ScienceDirect:Open Access CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE MEDLINE - Academic |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Biology |
| EISSN | 1935-3456 |
| EndPage | 286 |
| ExternalDocumentID | 36935091 10_1016_j_mucimm_2023_03_003 S1933021923000181 |
| Genre | Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- -Q- .1- .FO 0R~ 123 29M 39C 4.4 53G 70F 7X7 88E 8FI 8FJ AALRI AANZL AAXUO AAYWO ABAWZ ABUWG ACGFS ACKTT ACRQY ACVFH ADBBV ADCNI ADVLN AEJRE AENEX AEUPX AEXQZ AEXYK AFJKZ AFKRA AFPUW AFRHN AFSHS AGAYW AGHAI AHMBA AHSBF AIGII AILAN AITUG AJRNO AJUYK AKBMS AKRWK AKYEP ALFFA ALMA_UNASSIGNED_HOLDINGS AMRAJ AMYLF APXCP AXYYD BBNVY BENPR BHPHI BKKNO BPHCQ BVXVI CAG CCPQU COF CS3 DNIVK DU5 EBS EE. EIOEI EJD F5P FDB FDQFY FERAY FIZPM FSGXE FYUFA HCIFZ HMCUK HZ~ IWAJR JSO JZLTJ M1P M7P NQJWS O9- OK1 P2P PHGZM PHGZT PJZUB PPXIY PQGLB PQQKQ PROAC PSQYO PUEGO RNT RNTTT ROL SNYQT SRMVM SWTZT TAOOD TBHMF TDRGL TSG UKHRP Z5R 6I. AAFTH ACZOJ AFCTW ALIPV AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c527t-ac7d61b96a83fb5969e04d8efa2d7ec45223396513ec1b1b39652bfe183c233f3 |
| ISSN | 1933-0219 1935-3456 |
| IngestDate | Fri Jul 11 10:35:53 EDT 2025 Mon Jul 21 05:57:13 EDT 2025 Tue Jul 01 04:25:32 EDT 2025 Thu Apr 24 23:01:53 EDT 2025 Sun Apr 06 06:55:39 EDT 2025 Tue Aug 26 19:30:25 EDT 2025 |
| IsDoiOpenAccess | true |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 3 |
| Language | English |
| License | This is an open access article under the CC BY license. Copyright © 2023 The Author(s). Published by Elsevier Inc. All rights reserved. |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c527t-ac7d61b96a83fb5969e04d8efa2d7ec45223396513ec1b1b39652bfe183c233f3 |
| Notes | ObjectType-Article-1 SourceType-Scholarly Journals-1 ObjectType-Feature-2 content type line 23 |
| ORCID | 0000-0002-3384-7414 |
| OpenAccessLink | https://dx.doi.org/10.1016/j.mucimm.2023.03.003 |
| PMID | 36935091 |
| PQID | 2788804186 |
| PQPubID | 23479 |
| PageCount | 12 |
| ParticipantIDs | proquest_miscellaneous_2788804186 pubmed_primary_36935091 crossref_primary_10_1016_j_mucimm_2023_03_003 crossref_citationtrail_10_1016_j_mucimm_2023_03_003 elsevier_sciencedirect_doi_10_1016_j_mucimm_2023_03_003 elsevier_clinicalkey_doi_10_1016_j_mucimm_2023_03_003 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | June 2023 2023-06-00 20230601 |
| PublicationDateYYYYMMDD | 2023-06-01 |
| PublicationDate_xml | – month: 06 year: 2023 text: June 2023 |
| PublicationDecade | 2020 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | Mucosal immunology |
| PublicationTitleAlternate | Mucosal Immunol |
| PublicationYear | 2023 |
| Publisher | Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc |
| References | Wu, Metcalf (b0260) 2020; 12 Zhang (b0235) 2017; 114 Van Hoeven (b0075) 2017; 7 Jeyanathan (b0165) 2017; 199 Asahi (b0085) 2002; 168 Belyakov, Ahlers (b0090) 2009; 183 Sozzani, Vermi, Del Prete, Facchetti (b0220) 2010; 31 Ye (b0245) 2019; 20 Reizis, Colonna, Trinchieri, Barrat, Gilliet (b0170) 2011; 11 Björck, Leong, Engleman (b0240) 2011; 186 Renegar, Small, Boykins, Wright (b0020) 2004; 173 Tamura, Ainai, Suzuki, Kurata, Hasegawa (b0080) 2016; 69 Cerutti (b0015) 2008; 8 Kawai, Akira (b0110) 2006; 13 Asselin-Paturel (b0150) 2005; 201 Lycke (b0005) 2012; 12 Ishii, Akira (b0035) 2007; 27 Gürsel, Verthelyi, Gürsel, Ishii, Klinman (b0205) 2002; 71 Villadangos, Young (b0180) 2008; 29 Ichinohe (b0065) 2007; 9 Pulendran, Ahmed (b0025) 2006; 124 de Heer (b0200) 2004; 200 Mutsch (b0255) 2004; 350 Lombardi (b0210) 2008; 38 Ruane (b0185) 2016; 213 Fujkuyama (b0010) 2012; 11 Koyama (b0060) 2010; 2 Mathan, Figdor, Buschow (b0230) 2013; 4 Kohrgruber (b0155) 2004; 173 Wareing, Lyon, Lu, Gerard, Sarawar (b0130) 2004; 76 Lindell, Lane, Lukacs (b0125) 2008; 38 Ye (b0250) 2019; 93 Chang (b0135) 2013; 110 Ato (b0100) 2013; 31 Ichinohe (b0070) 2007; 196 Chaturvedi (b0160) 2015; 125 Bemark, Boysen, Lycke (b0190) 2012; 1247 Asselin-Paturel, Brizard, Pin, Brière, Trinchieri (b0195) 2003; 171 Dalrymple, Mackow (b0145) 2012; 86 Colonna, Cella (b0175) 2007; 27 Holmgren, Czerkinsky (b0095) 2005; 11 Chang, Ko, Kweon (b0040) 2014; 46 Gilliet, Cao, Liu (b0105) 2008; 8 Swiecki (b0225) 2017; 10 Tokunaga (b0115) 2018; 63 Koyama (b0055) 2007; 179 Palm, Medzhitov (b0030) 2009; 227 Sauty (b0140) 2001; 167 Kohlmeier (b0120) 2009; 183 Tezuka (b0050) 2011; 34 Tezuka (b0045) 2007; 448 Caproni (b0215) 2012; 188 Wareing (10.1016/j.mucimm.2023.03.003_b0130) 2004; 76 Fujkuyama (10.1016/j.mucimm.2023.03.003_b0010) 2012; 11 Villadangos (10.1016/j.mucimm.2023.03.003_b0180) 2008; 29 Palm (10.1016/j.mucimm.2023.03.003_b0030) 2009; 227 Gilliet (10.1016/j.mucimm.2023.03.003_b0105) 2008; 8 Ye (10.1016/j.mucimm.2023.03.003_b0250) 2019; 93 Colonna (10.1016/j.mucimm.2023.03.003_b0175) 2007; 27 Asselin-Paturel (10.1016/j.mucimm.2023.03.003_b0150) 2005; 201 Kawai (10.1016/j.mucimm.2023.03.003_b0110) 2006; 13 Asahi (10.1016/j.mucimm.2023.03.003_b0085) 2002; 168 Kohrgruber (10.1016/j.mucimm.2023.03.003_b0155) 2004; 173 Lombardi (10.1016/j.mucimm.2023.03.003_b0210) 2008; 38 Sauty (10.1016/j.mucimm.2023.03.003_b0140) 2001; 167 Pulendran (10.1016/j.mucimm.2023.03.003_b0025) 2006; 124 Asselin-Paturel (10.1016/j.mucimm.2023.03.003_b0195) 2003; 171 Dalrymple (10.1016/j.mucimm.2023.03.003_b0145) 2012; 86 Tezuka (10.1016/j.mucimm.2023.03.003_b0045) 2007; 448 Ichinohe (10.1016/j.mucimm.2023.03.003_b0070) 2007; 196 de Heer (10.1016/j.mucimm.2023.03.003_b0200) 2004; 200 Renegar (10.1016/j.mucimm.2023.03.003_b0020) 2004; 173 Holmgren (10.1016/j.mucimm.2023.03.003_b0095) 2005; 11 Zhang (10.1016/j.mucimm.2023.03.003_b0235) 2017; 114 Ichinohe (10.1016/j.mucimm.2023.03.003_b0065) 2007; 9 Chang (10.1016/j.mucimm.2023.03.003_b0135) 2013; 110 Wu (10.1016/j.mucimm.2023.03.003_b0260) 2020; 12 Kohlmeier (10.1016/j.mucimm.2023.03.003_b0120) 2009; 183 Tezuka (10.1016/j.mucimm.2023.03.003_b0050) 2011; 34 Tamura (10.1016/j.mucimm.2023.03.003_b0080) 2016; 69 Jeyanathan (10.1016/j.mucimm.2023.03.003_b0165) 2017; 199 Lycke (10.1016/j.mucimm.2023.03.003_b0005) 2012; 12 Sozzani (10.1016/j.mucimm.2023.03.003_b0220) 2010; 31 Reizis (10.1016/j.mucimm.2023.03.003_b0170) 2011; 11 Ruane (10.1016/j.mucimm.2023.03.003_b0185) 2016; 213 Belyakov (10.1016/j.mucimm.2023.03.003_b0090) 2009; 183 Mutsch (10.1016/j.mucimm.2023.03.003_b0255) 2004; 350 Ato (10.1016/j.mucimm.2023.03.003_b0100) 2013; 31 Koyama (10.1016/j.mucimm.2023.03.003_b0060) 2010; 2 Ishii (10.1016/j.mucimm.2023.03.003_b0035) 2007; 27 Mathan (10.1016/j.mucimm.2023.03.003_b0230) 2013; 4 Van Hoeven (10.1016/j.mucimm.2023.03.003_b0075) 2017; 7 Tokunaga (10.1016/j.mucimm.2023.03.003_b0115) 2018; 63 Swiecki (10.1016/j.mucimm.2023.03.003_b0225) 2017; 10 Gürsel (10.1016/j.mucimm.2023.03.003_b0205) 2002; 71 Bemark (10.1016/j.mucimm.2023.03.003_b0190) 2012; 1247 Koyama (10.1016/j.mucimm.2023.03.003_b0055) 2007; 179 Björck (10.1016/j.mucimm.2023.03.003_b0240) 2011; 186 Caproni (10.1016/j.mucimm.2023.03.003_b0215) 2012; 188 Lindell (10.1016/j.mucimm.2023.03.003_b0125) 2008; 38 Chaturvedi (10.1016/j.mucimm.2023.03.003_b0160) 2015; 125 Cerutti (10.1016/j.mucimm.2023.03.003_b0015) 2008; 8 Ye (10.1016/j.mucimm.2023.03.003_b0245) 2019; 20 Chang (10.1016/j.mucimm.2023.03.003_b0040) 2014; 46 |
| References_xml | – volume: 8 start-page: 421 year: 2008 end-page: 434 ident: b0015 article-title: The regulation of IgA class switching publication-title: Nat. Rev. Immunol. – volume: 20 start-page: 593 year: 2019 end-page: 601 ident: b0245 article-title: Interferon–λ enhances adaptive mucosal immunity by boosting release of thymic stromal lymphopoietin publication-title: Nat. Immunol. – volume: 227 start-page: 221 year: 2009 end-page: 233 ident: b0030 article-title: Pattern recognition receptors and control of adaptive immunity publication-title: Immunol. Rev. – volume: 173 start-page: 6592 year: 2004 end-page: 6602 ident: b0155 article-title: Plasmacytoid dendritic cell recruitment by immobilized CXCR3 ligands publication-title: J. Immunol. – volume: 200 start-page: 89 year: 2004 end-page: 98 ident: b0200 article-title: Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen publication-title: J. Exp. Med. – volume: 12 start-page: 437 year: 2020 end-page: 447 ident: b0260 article-title: The role of Type I IFNs in influenza: antiviral superheroes or immunopathogenic villains? publication-title: J. Innate Immun. – volume: 213 start-page: 53 year: 2016 end-page: 73 ident: b0185 article-title: Microbiota regulate the ability of lung dendritic cells to induce IgA class–switch recombination and generate protective gastrointestinal immune responses publication-title: J. Exp. Med. – volume: 93 year: 2019 ident: b0250 article-title: Type I and Type III interferons differ in their adjuvant activities for influenza vaccines publication-title: J. Virol. – volume: 179 start-page: 4711 year: 2007 end-page: 4720 ident: b0055 article-title: Differential role of TLR– and RLR–signaling in the immune responses to influenza A virus infection and vaccination publication-title: J. Immunol. – volume: 188 start-page: 3088 year: 2012 end-page: 3098 ident: b0215 article-title: MF59 and Pam3CSK4 boost adaptive responses to influenza subunit vaccine through an IFN type I–independent mechanism of action publication-title: J. Immunol. – volume: 10 start-page: 936 year: 2017 end-page: 945 ident: b0225 article-title: Microbiota induces tonic CCL2 systemic levels that control pDC trafficking in steady state publication-title: Mucosal Immunol. – volume: 196 start-page: 1313 year: 2007 end-page: 1320 ident: b0070 article-title: Cross–protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine publication-title: J. Infect. Dis. – volume: 86 start-page: 6408 year: 2012 end-page: 6415 ident: b0145 article-title: Endothelial cells elicit immune–enhancing responses to dengue virus infection publication-title: J. Virol. – volume: 4 start-page: 372 year: 2013 ident: b0230 article-title: Human plasmacytoid dendritic cells: from molecules to intercellular communication network publication-title: Front. Immunol. – volume: 1247 start-page: 97 year: 2012 end-page: 116 ident: b0190 article-title: Induction of gut IgA production through T cell–dependent and T cell–independent pathways publication-title: Ann. N. Y. Acad. Sci. – volume: 201 start-page: 1157 year: 2005 end-page: 1167 ident: b0150 article-title: Type I interferon dependence of plasmacytoid dendritic cell activation and migration publication-title: J. Exp. Med. – volume: 29 start-page: 352 year: 2008 end-page: 361 ident: b0180 article-title: Antigen–presentation properties of plasmacytoid dendritic cells publication-title: Immunity – volume: 168 start-page: 2930 year: 2002 end-page: 2938 ident: b0085 article-title: Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant–combined vaccines publication-title: J. Immunol. – volume: 124 start-page: 849 year: 2006 end-page: 863 ident: b0025 article-title: Translating innate immunity into immunological memory: implications for vaccine development publication-title: Cell – volume: 167 start-page: 7084 year: 2001 end-page: 7093 ident: b0140 article-title: CXCR3 internalization following T cell–endothelial cell contact: preferential role of IFN–inducible T cell alpha chemoattractant (CXCL11) publication-title: J. Immunol. – volume: 11 start-page: S45 year: 2005 end-page: 53 ident: b0095 article-title: Mucosal immunity and vaccines publication-title: Nat. Med. – volume: 350 start-page: 896 year: 2004 end-page: 903 ident: b0255 article-title: Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland publication-title: N. Engl. J. Med. – volume: 183 start-page: 6883 year: 2009 end-page: 6892 ident: b0090 article-title: What role does the route of immunization play in the generation of protective immunity against mucosal pathogens? publication-title: J. Immunol. – volume: 38 start-page: 1819 year: 2008 end-page: 1829 ident: b0210 article-title: Toll–like receptor 2 agonist Pam3CSK4 enhances the induction of antigen–specific tolerance via the sublingual route publication-title: Clin. Exp. Allergy – volume: 27 start-page: 419 year: 2007 end-page: 421 ident: b0175 article-title: Crosspresentation: plasmacytoid dendritic cells are in the business publication-title: Immunity – volume: 114 start-page: 1988 year: 2017 end-page: 1993 ident: b0235 article-title: A distinct subset of plasmacytoid dendritic cells induces activation and differentiation of B and T lymphocytes publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 34 start-page: 247 year: 2011 end-page: 257 ident: b0050 article-title: Prominent role for plasmacytoid dendritic cells in mucosal T cell–independent IgA induction publication-title: Immunity – volume: 27 start-page: 363 year: 2007 end-page: 371 ident: b0035 article-title: Toll or toll–free adjuvant path toward the optimal vaccine development publication-title: J. Clin. Immunol. – volume: 46 year: 2014 ident: b0040 article-title: Mucosal dendritic cells shape mucosal immunity publication-title: Exp. Mol. Med. – volume: 125 start-page: 1713 year: 2015 end-page: 1725 ident: b0160 article-title: CXCR3 blockade protects against Listeria monocytogenes infection–induced fetal wastage publication-title: J. Clin. Invest. – volume: 448 start-page: 929 year: 2007 end-page: 933 ident: b0045 article-title: Regulation of IgA production by naturally occurring TNF/iNOS–producing dendritic cells publication-title: Nature – volume: 199 start-page: 2555 year: 2017 end-page: 2569 ident: b0165 article-title: CXCR3 signaling is required for restricted homing of parenteral tuberculosis vaccine–induced T cells to both the lung parenchyma and airway publication-title: J. Immunol. – volume: 71 start-page: 813 year: 2002 end-page: 820 ident: b0205 article-title: Differential and competitive activation of human immune cells by distinct classes of CpG oligodeoxynucleotide publication-title: J. Leukoc. Biol. – volume: 8 start-page: 594 year: 2008 end-page: 606 ident: b0105 article-title: Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases publication-title: Nat. Rev. Immunol. – volume: 13 start-page: 816 year: 2006 end-page: 825 ident: b0110 article-title: TLR signaling publication-title: Cell Death Differ. – volume: 31 start-page: 270 year: 2010 end-page: 277 ident: b0220 article-title: Trafficking properties of plasmacytoid dendritic cells in health and disease publication-title: Trends Immunol. – volume: 186 start-page: 1477 year: 2011 end-page: 1485 ident: b0240 article-title: Plasmacytoid dendritic cell dichotomy: identification of IFN–α producing cells as a phenotypically and functionally distinct subset publication-title: J. Immunol. – volume: 31 start-page: 2184 year: 2013 end-page: 2190 ident: b0100 article-title: Influenza A whole virion vaccine induces a rapid reduction of peripheral blood leukocytes via interferon–α–dependent apoptosis publication-title: Vaccine – volume: 12 start-page: 592 year: 2012 end-page: 605 ident: b0005 article-title: Recent progress in mucosal vaccine development: potential and limitations publication-title: Nat. Rev. Immunol. – volume: 2 start-page: 25ra24 year: 2010 ident: b0060 article-title: Plasmacytoid dendritic cells delineate immunogenicity of influenza vaccine subtypes publication-title: Sci. Transl. Med. – volume: 173 start-page: 1978 year: 2004 end-page: 1986 ident: b0020 article-title: Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract publication-title: J. Immunol. – volume: 63 start-page: 40 year: 2018 end-page: 47 ident: b0115 article-title: CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy publication-title: Cancer Treat. Rev. – volume: 9 start-page: 1333 year: 2007 end-page: 1340 ident: b0065 article-title: Intranasal immunization with H5N1 vaccine plus Poly I:poly C12U, a Toll–like receptor agonist, protects mice against homologous and heterologous virus challenge publication-title: Microbes Infect. – volume: 11 start-page: 367 year: 2012 end-page: 379 ident: b0010 article-title: Novel vaccine development strategies for inducing mucosal immunity publication-title: Expert Rev. Vaccines – volume: 38 start-page: 2168 year: 2008 end-page: 2179 ident: b0125 article-title: CXCL10/CXCR3–mediated responses promote immunity to respiratory syncytial virus infection by augmenting dendritic cell and CD8(+) T cell efficacy publication-title: Eur. J. Immunol. – volume: 11 start-page: 558 year: 2011 end-page: 565 ident: b0170 article-title: Plasmacytoid dendritic cells: one–trick ponies or workhorses of the immune system? publication-title: Nat. Rev. Immunol. – volume: 183 start-page: 4378 year: 2009 end-page: 4384 ident: b0120 article-title: CXCR3 directs antigen–specific effector CD4+ T cell migration to the lung during parainfluenza virus infection publication-title: J. Immunol. – volume: 171 start-page: 6466 year: 2003 end-page: 6477 ident: b0195 article-title: Mouse strain differences in plasmacytoid dendritic cell frequency and function revealed by a novel monoclonal antibody publication-title: J. Immunol. – volume: 110 start-page: 18042 year: 2013 end-page: 18051 ident: b0135 article-title: Lung epithelial branching program antagonizes alveolar differentiation publication-title: Proc. Natl. Acad. Sci. U. S. A. – volume: 69 start-page: 165 year: 2016 end-page: 179 ident: b0080 article-title: Intranasal inactivated influenza vaccines: a reasonable approach to improve the efficacy of influenza vaccine? publication-title: Jpn. J. Infect. Dis. – volume: 7 start-page: 46426 year: 2017 ident: b0075 article-title: A formulated TLR7/8 agonist is a flexible, highly potent and effective adjuvant for pandemic influenza vaccines publication-title: Sci. Rep. – volume: 76 start-page: 886 year: 2004 end-page: 895 ident: b0130 article-title: Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice publication-title: J. Leukoc. Biol. – volume: 168 start-page: 2930 year: 2002 ident: 10.1016/j.mucimm.2023.03.003_b0085 article-title: Protection against influenza virus infection in polymeric Ig receptor knockout mice immunized intranasally with adjuvant–combined vaccines publication-title: J. Immunol. doi: 10.4049/jimmunol.168.6.2930 – volume: 114 start-page: 1988 year: 2017 ident: 10.1016/j.mucimm.2023.03.003_b0235 article-title: A distinct subset of plasmacytoid dendritic cells induces activation and differentiation of B and T lymphocytes publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.1610630114 – volume: 12 start-page: 437 year: 2020 ident: 10.1016/j.mucimm.2023.03.003_b0260 article-title: The role of Type I IFNs in influenza: antiviral superheroes or immunopathogenic villains? publication-title: J. Innate Immun. doi: 10.1159/000508379 – volume: 38 start-page: 2168 year: 2008 ident: 10.1016/j.mucimm.2023.03.003_b0125 article-title: CXCL10/CXCR3–mediated responses promote immunity to respiratory syncytial virus infection by augmenting dendritic cell and CD8(+) T cell efficacy publication-title: Eur. J. Immunol. doi: 10.1002/eji.200838155 – volume: 125 start-page: 1713 year: 2015 ident: 10.1016/j.mucimm.2023.03.003_b0160 article-title: CXCR3 blockade protects against Listeria monocytogenes infection–induced fetal wastage publication-title: J. Clin. Invest. doi: 10.1172/JCI78578 – volume: 8 start-page: 594 year: 2008 ident: 10.1016/j.mucimm.2023.03.003_b0105 article-title: Plasmacytoid dendritic cells: sensing nucleic acids in viral infection and autoimmune diseases publication-title: Nat. Rev. Immunol. doi: 10.1038/nri2358 – volume: 38 start-page: 1819 year: 2008 ident: 10.1016/j.mucimm.2023.03.003_b0210 article-title: Toll–like receptor 2 agonist Pam3CSK4 enhances the induction of antigen–specific tolerance via the sublingual route publication-title: Clin. Exp. Allergy doi: 10.1111/j.1365-2222.2008.03056.x – volume: 167 start-page: 7084 year: 2001 ident: 10.1016/j.mucimm.2023.03.003_b0140 article-title: CXCR3 internalization following T cell–endothelial cell contact: preferential role of IFN–inducible T cell alpha chemoattractant (CXCL11) publication-title: J. Immunol. doi: 10.4049/jimmunol.167.12.7084 – volume: 11 start-page: S45 year: 2005 ident: 10.1016/j.mucimm.2023.03.003_b0095 article-title: Mucosal immunity and vaccines publication-title: Nat. Med. doi: 10.1038/nm1213 – volume: 183 start-page: 6883 year: 2009 ident: 10.1016/j.mucimm.2023.03.003_b0090 article-title: What role does the route of immunization play in the generation of protective immunity against mucosal pathogens? publication-title: J. Immunol. doi: 10.4049/jimmunol.0901466 – volume: 34 start-page: 247 year: 2011 ident: 10.1016/j.mucimm.2023.03.003_b0050 article-title: Prominent role for plasmacytoid dendritic cells in mucosal T cell–independent IgA induction publication-title: Immunity doi: 10.1016/j.immuni.2011.02.002 – volume: 199 start-page: 2555 year: 2017 ident: 10.1016/j.mucimm.2023.03.003_b0165 article-title: CXCR3 signaling is required for restricted homing of parenteral tuberculosis vaccine–induced T cells to both the lung parenchyma and airway publication-title: J. Immunol. doi: 10.4049/jimmunol.1700382 – volume: 11 start-page: 558 year: 2011 ident: 10.1016/j.mucimm.2023.03.003_b0170 article-title: Plasmacytoid dendritic cells: one–trick ponies or workhorses of the immune system? publication-title: Nat. Rev. Immunol. doi: 10.1038/nri3027 – volume: 171 start-page: 6466 year: 2003 ident: 10.1016/j.mucimm.2023.03.003_b0195 article-title: Mouse strain differences in plasmacytoid dendritic cell frequency and function revealed by a novel monoclonal antibody publication-title: J. Immunol. doi: 10.4049/jimmunol.171.12.6466 – volume: 31 start-page: 270 year: 2010 ident: 10.1016/j.mucimm.2023.03.003_b0220 article-title: Trafficking properties of plasmacytoid dendritic cells in health and disease publication-title: Trends Immunol. doi: 10.1016/j.it.2010.05.004 – volume: 69 start-page: 165 year: 2016 ident: 10.1016/j.mucimm.2023.03.003_b0080 article-title: Intranasal inactivated influenza vaccines: a reasonable approach to improve the efficacy of influenza vaccine? publication-title: Jpn. J. Infect. Dis. doi: 10.7883/yoken.JJID.2015.560 – volume: 186 start-page: 1477 year: 2011 ident: 10.1016/j.mucimm.2023.03.003_b0240 article-title: Plasmacytoid dendritic cell dichotomy: identification of IFN–α producing cells as a phenotypically and functionally distinct subset publication-title: J. Immunol. doi: 10.4049/jimmunol.1000454 – volume: 71 start-page: 813 year: 2002 ident: 10.1016/j.mucimm.2023.03.003_b0205 article-title: Differential and competitive activation of human immune cells by distinct classes of CpG oligodeoxynucleotide publication-title: J. Leukoc. Biol. doi: 10.1189/jlb.71.5.813 – volume: 8 start-page: 421 year: 2008 ident: 10.1016/j.mucimm.2023.03.003_b0015 article-title: The regulation of IgA class switching publication-title: Nat. Rev. Immunol. doi: 10.1038/nri2322 – volume: 46 year: 2014 ident: 10.1016/j.mucimm.2023.03.003_b0040 article-title: Mucosal dendritic cells shape mucosal immunity publication-title: Exp. Mol. Med. doi: 10.1038/emm.2014.16 – volume: 11 start-page: 367 year: 2012 ident: 10.1016/j.mucimm.2023.03.003_b0010 article-title: Novel vaccine development strategies for inducing mucosal immunity publication-title: Expert Rev. Vaccines doi: 10.1586/erv.11.196 – volume: 63 start-page: 40 year: 2018 ident: 10.1016/j.mucimm.2023.03.003_b0115 article-title: CXCL9, CXCL10, CXCL11/CXCR3 axis for immune activation – A target for novel cancer therapy publication-title: Cancer Treat. Rev. doi: 10.1016/j.ctrv.2017.11.007 – volume: 110 start-page: 18042 year: 2013 ident: 10.1016/j.mucimm.2023.03.003_b0135 article-title: Lung epithelial branching program antagonizes alveolar differentiation publication-title: Proc. Natl. Acad. Sci. U. S. A. doi: 10.1073/pnas.1311760110 – volume: 213 start-page: 53 year: 2016 ident: 10.1016/j.mucimm.2023.03.003_b0185 article-title: Microbiota regulate the ability of lung dendritic cells to induce IgA class–switch recombination and generate protective gastrointestinal immune responses publication-title: J. Exp. Med. doi: 10.1084/jem.20150567 – volume: 173 start-page: 1978 year: 2004 ident: 10.1016/j.mucimm.2023.03.003_b0020 article-title: Role of IgA versus IgG in the control of influenza viral infection in the murine respiratory tract publication-title: J. Immunol. doi: 10.4049/jimmunol.173.3.1978 – volume: 31 start-page: 2184 year: 2013 ident: 10.1016/j.mucimm.2023.03.003_b0100 article-title: Influenza A whole virion vaccine induces a rapid reduction of peripheral blood leukocytes via interferon–α–dependent apoptosis publication-title: Vaccine doi: 10.1016/j.vaccine.2013.02.016 – volume: 9 start-page: 1333 year: 2007 ident: 10.1016/j.mucimm.2023.03.003_b0065 article-title: Intranasal immunization with H5N1 vaccine plus Poly I:poly C12U, a Toll–like receptor agonist, protects mice against homologous and heterologous virus challenge publication-title: Microbes Infect. doi: 10.1016/j.micinf.2007.06.007 – volume: 196 start-page: 1313 year: 2007 ident: 10.1016/j.mucimm.2023.03.003_b0070 article-title: Cross–protection against H5N1 influenza virus infection is afforded by intranasal inoculation with seasonal trivalent inactivated influenza vaccine publication-title: J. Infect. Dis. doi: 10.1086/521304 – volume: 12 start-page: 592 year: 2012 ident: 10.1016/j.mucimm.2023.03.003_b0005 article-title: Recent progress in mucosal vaccine development: potential and limitations publication-title: Nat. Rev. Immunol. doi: 10.1038/nri3251 – volume: 2 start-page: 25ra24 year: 2010 ident: 10.1016/j.mucimm.2023.03.003_b0060 article-title: Plasmacytoid dendritic cells delineate immunogenicity of influenza vaccine subtypes publication-title: Sci. Transl. Med. doi: 10.1126/scitranslmed.3000759 – volume: 29 start-page: 352 year: 2008 ident: 10.1016/j.mucimm.2023.03.003_b0180 article-title: Antigen–presentation properties of plasmacytoid dendritic cells publication-title: Immunity doi: 10.1016/j.immuni.2008.09.002 – volume: 4 start-page: 372 year: 2013 ident: 10.1016/j.mucimm.2023.03.003_b0230 article-title: Human plasmacytoid dendritic cells: from molecules to intercellular communication network publication-title: Front. Immunol. doi: 10.3389/fimmu.2013.00372 – volume: 350 start-page: 896 year: 2004 ident: 10.1016/j.mucimm.2023.03.003_b0255 article-title: Use of the inactivated intranasal influenza vaccine and the risk of Bell's palsy in Switzerland publication-title: N. Engl. J. Med. doi: 10.1056/NEJMoa030595 – volume: 124 start-page: 849 year: 2006 ident: 10.1016/j.mucimm.2023.03.003_b0025 article-title: Translating innate immunity into immunological memory: implications for vaccine development publication-title: Cell doi: 10.1016/j.cell.2006.02.019 – volume: 86 start-page: 6408 year: 2012 ident: 10.1016/j.mucimm.2023.03.003_b0145 article-title: Endothelial cells elicit immune–enhancing responses to dengue virus infection publication-title: J. Virol. doi: 10.1128/JVI.00213-12 – volume: 10 start-page: 936 year: 2017 ident: 10.1016/j.mucimm.2023.03.003_b0225 article-title: Microbiota induces tonic CCL2 systemic levels that control pDC trafficking in steady state publication-title: Mucosal Immunol. doi: 10.1038/mi.2016.99 – volume: 179 start-page: 4711 year: 2007 ident: 10.1016/j.mucimm.2023.03.003_b0055 article-title: Differential role of TLR– and RLR–signaling in the immune responses to influenza A virus infection and vaccination publication-title: J. Immunol. doi: 10.4049/jimmunol.179.7.4711 – volume: 76 start-page: 886 year: 2004 ident: 10.1016/j.mucimm.2023.03.003_b0130 article-title: Chemokine expression during the development and resolution of a pulmonary leukocyte response to influenza A virus infection in mice publication-title: J. Leukoc. Biol. doi: 10.1189/jlb.1203644 – volume: 448 start-page: 929 year: 2007 ident: 10.1016/j.mucimm.2023.03.003_b0045 article-title: Regulation of IgA production by naturally occurring TNF/iNOS–producing dendritic cells publication-title: Nature doi: 10.1038/nature06033 – volume: 173 start-page: 6592 year: 2004 ident: 10.1016/j.mucimm.2023.03.003_b0155 article-title: Plasmacytoid dendritic cell recruitment by immobilized CXCR3 ligands publication-title: J. Immunol. doi: 10.4049/jimmunol.173.11.6592 – volume: 20 start-page: 593 year: 2019 ident: 10.1016/j.mucimm.2023.03.003_b0245 article-title: Interferon–λ enhances adaptive mucosal immunity by boosting release of thymic stromal lymphopoietin publication-title: Nat. Immunol. doi: 10.1038/s41590-019-0345-x – volume: 183 start-page: 4378 year: 2009 ident: 10.1016/j.mucimm.2023.03.003_b0120 article-title: CXCR3 directs antigen–specific effector CD4+ T cell migration to the lung during parainfluenza virus infection publication-title: J. Immunol. doi: 10.4049/jimmunol.0902022 – volume: 188 start-page: 3088 year: 2012 ident: 10.1016/j.mucimm.2023.03.003_b0215 article-title: MF59 and Pam3CSK4 boost adaptive responses to influenza subunit vaccine through an IFN type I–independent mechanism of action publication-title: J. Immunol. doi: 10.4049/jimmunol.1101764 – volume: 1247 start-page: 97 year: 2012 ident: 10.1016/j.mucimm.2023.03.003_b0190 article-title: Induction of gut IgA production through T cell–dependent and T cell–independent pathways publication-title: Ann. N. Y. Acad. Sci. doi: 10.1111/j.1749-6632.2011.06378.x – volume: 13 start-page: 816 year: 2006 ident: 10.1016/j.mucimm.2023.03.003_b0110 article-title: TLR signaling publication-title: Cell Death Differ. doi: 10.1038/sj.cdd.4401850 – volume: 27 start-page: 363 year: 2007 ident: 10.1016/j.mucimm.2023.03.003_b0035 article-title: Toll or toll–free adjuvant path toward the optimal vaccine development publication-title: J. Clin. Immunol. doi: 10.1007/s10875-007-9087-x – volume: 200 start-page: 89 year: 2004 ident: 10.1016/j.mucimm.2023.03.003_b0200 article-title: Essential role of lung plasmacytoid dendritic cells in preventing asthmatic reactions to harmless inhaled antigen publication-title: J. Exp. Med. doi: 10.1084/jem.20040035 – volume: 201 start-page: 1157 year: 2005 ident: 10.1016/j.mucimm.2023.03.003_b0150 article-title: Type I interferon dependence of plasmacytoid dendritic cell activation and migration publication-title: J. Exp. Med. doi: 10.1084/jem.20041930 – volume: 7 start-page: 46426 year: 2017 ident: 10.1016/j.mucimm.2023.03.003_b0075 article-title: A formulated TLR7/8 agonist is a flexible, highly potent and effective adjuvant for pandemic influenza vaccines publication-title: Sci. Rep. doi: 10.1038/srep46426 – volume: 227 start-page: 221 year: 2009 ident: 10.1016/j.mucimm.2023.03.003_b0030 article-title: Pattern recognition receptors and control of adaptive immunity publication-title: Immunol. Rev. doi: 10.1111/j.1600-065X.2008.00731.x – volume: 27 start-page: 419 year: 2007 ident: 10.1016/j.mucimm.2023.03.003_b0175 article-title: Crosspresentation: plasmacytoid dendritic cells are in the business publication-title: Immunity doi: 10.1016/j.immuni.2007.08.006 – volume: 93 year: 2019 ident: 10.1016/j.mucimm.2023.03.003_b0250 article-title: Type I and Type III interferons differ in their adjuvant activities for influenza vaccines publication-title: J. Virol. doi: 10.1128/JVI.01262-19 |
| SSID | ssj0060053 |
| Score | 2.3725252 |
| Snippet | The stimulation of local immunity by vaccination is desirable for controlling virus replication in the respiratory tract. However, the local immune stimulatory... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 275 |
| SubjectTerms | Adjuvants, Immunologic Administration, Intranasal Animals Antibodies, Viral Dendritic Cells Immunity, Mucosal Immunoglobulin A Immunoglobulin G Influenza Vaccines Interferon Type I Mice Mice, Inbred BALB C |
| Title | Systemically inoculated adjuvants stimulate pDC-dependent IgA response in local site |
| URI | https://www.clinicalkey.com/#!/content/1-s2.0-S1933021923000181 https://dx.doi.org/10.1016/j.mucimm.2023.03.003 https://www.ncbi.nlm.nih.gov/pubmed/36935091 https://www.proquest.com/docview/2788804186 |
| Volume | 16 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1ba9swFBahZbCXsfuyGx7sLTjYlq3Yj6FryRa6hzVlfTOSLG1Jmrgk9mD79TvHshSHrrTrizFKTiLrfD4X6VwI-QgqVQhQnOCbBNyPdcJ9MI4iX6ahTgWnKgowd_j0K5ucx18ukoteT3eilupKDOWff-aV3IerMAZ8xSzZ_-Cs-1EYgHvgL1yBw3C9E49NuXFc5ktM3ysxphQtSF4s6l9NgAu8wKtmcHD16ci3HW-rwecf48HGhMc2VUMalTbAk-SutXqK4exYlQOTSPb238_4lpuG18fzykn28Zav61Vjjk7mhVrOHTvLVdvBccI39dIRnNSb-ic3BuxUzZdldxMiortgKbMzZrNj9oI3wTbEM-JWJFppyzqool3RaTqotFo4MgWyrwl4s9ewGK5qCc8-xLmYIrV0p9BcmOEZzgAnAH4Wdh8EL_kwAncC5OHhePrt-9TqbIayyMQfmBnbJMsmEvD6f91kxNzkpDTGyuwxedR6Gd7YQOYJ6an1U_LA9B39_YzMusDxdsDxHHA8BxxvDzgeAMezwAFKrwGOh8B5Ts5PjmdHE79tr-HLJBpVPpejgoUiYzylWiQZy1QQF6nSPCpGSmKpfUozloRUyVCEAu8joRUoAQmfaPqCHKzLtXpFvBBrFIWJliJhMSsCzmUcxlLDktNIB2mfULteuWxrz2MLlMvcBhkucrPKOa5yHlCsWdsnvqO6MrVXbvl-YlmR27xi0IQ5YOcWupGja-1OY0_egfKD5XgOYhnP2vhalfU2j3BrKYjDlPXJSwMF9wyUZRTt9Nf3nO8b8nD3Dr4lB9WmVu_ANK7E-xbXfwEfWLug |
| linkProvider | Library Specific Holdings |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Systemically+inoculated+adjuvants+stimulate+pDC-dependent+IgA+response+in+local+site&rft.jtitle=Mucosal+immunology&rft.au=Sasaki%2C+Eita&rft.au=Asanuma%2C+Hideki&rft.au=Momose%2C+Haruka&rft.au=Furuhata%2C+Keiko&rft.date=2023-06-01&rft.pub=Elsevier+Inc&rft.issn=1933-0219&rft.volume=16&rft.issue=3&rft.spage=275&rft.epage=286&rft_id=info:doi/10.1016%2Fj.mucimm.2023.03.003&rft.externalDocID=S1933021923000181 |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=1933-0219&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=1933-0219&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=1933-0219&client=summon |